No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3227 |
4. Check minimum number of eventsNone |
3227 |
5. Include endpointsNone |
3227 |
6. Filter based on genotype QC (FinnGen only) |
3227 |
Control definitions (FinnGen only)
- Control exclude
- H7_OCUMUSCLE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H50
- Name in latin
- Strabismus divergens concomitans
Similar endpoints
↥List of similar endpoints to
Divergent concomitant strabismus
based on the number of shared cases.
Similar with more cases:
- Other strabismus
- Strabismus
- Disorders of ocular muscles, binocular movement, accommodation and refraction
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 30557 | 17266 | 13194 |
| Only index persons | 27598 | 15794 | 11804 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.44 | 0.49 | 0.37 |
| Only index persons | 0.53 | 0.58 | 0.45 |
| Median age at first event (years) | |||
| Whole population | 13.93 | 14.80 | 12.62 |
| Only index persons | 13.95 | 14.85 | 12.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3227 | 2083 | 1144 |
| Unadjusted period prevalence (%) | 0.64 | 0.71 | 0.50 |
| Median age at first event (years) | 20.81 | 17.76 | 26.36 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2927
- Matched controls
- 29270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
3503
FHL
Single muscle retroposition
1784.8
323.0
311
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
16378.2
323.0
1067
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
+∞
323.0
443
*
H50.31
ICD-10 Finland
Intermittent exotropia
1510.6
323.0
393
*
37301
ICD-8 Finland
Strabismus, Concomitans divergens
+∞
323.0
1533
*
3781B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]
+∞
275.4
260
*
3781A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS CONCOMITANS DIVERGENS]
+∞
233.5
221
*
H50.52
ICD-10 Finland
Exophoria
175.6
218.2
227
14
3507
FHL
Retroposition and resection
+∞
191.8
182
*
CEC00
NOMESCO Finland
Recession of extraocular muscle
1900.8
177.9
171
*
37303
ICD-8 Finland
Strabismus, Heterophoria (exophoria, esophroria, hypophoria)
+∞
151.4
144
*
H50.2
ICD-10 Finland
Vertical strabismus
1486.8
145.0
140
*
37300
ICD-8 Finland
Strabismus, Concomitans convergens
+∞
132.3
126
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
+∞
104.8
100
*
3505
FHL
Single muscle resection
+∞
103.7
99
*
CEC30
NOMESCO Finland
Resection of extraocular muscle
1033.5
102.8
100
*
H53.0
ICD-10 Finland
Amblyopia ex anopsia
32.9
84.0
111
35
3782B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS DIVERGENS INTERMITTENS]
+∞
73.2
70
*
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
+∞
69.0
66
*
H53.2
ICD-10 Finland
Diplopia
8.0
64.4
151
197
CEW99
NOMESCO Finland
Other operation on extraocular muscle
+∞
58.5
56
*
H50.30
ICD-10 Finland
Intermittent esotropy
579.1
57.8
57
*
3504
FHL
Retroposition of two muscles
+∞
53.3
51
*
3784B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Heterophoria[EXOPHORIA]
+∞
50.1
48
*
37720
ICD-8 Finland
Other diseases of retina and optic nerve, Amblyopia
78.7
48.1
54
7
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.7
43.6
334
1347
WX140
NOMESCO Finland
Parabulbar anesthesy
4.4
43.5
167
401
H50.9
ICD-10 Finland
Strabismus, unspecified
68.1
41.1
47
7
H51.1
ICD-10 Finland
Convergence insufficiency and excess
+∞
40.7
39
*
H52.0
ICD-10 Finland
Hypermetropia
12.7
36.8
66
53
CEC50
NOMESCO Finland
Advancement of extraocular muscle
+∞
34.4
33
*
37302
ICD-8 Finland
Strabismus, Concomitans sursum sive deorsum vergens
+∞
33.4
32
*
H50.51
ICD-10 Finland
Esophoria
75.0
32.9
37
5
CEC20
NOMESCO Finland
Recession and advancement of extraocular muscle
+∞
32.3
31
*
3781X
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALIUS]
+∞
32.3
31
*
H52.1
ICD-10 Finland
Myopia
6.5
30.5
81
128
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
30.2
459
2536
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
29.7
814
5454
3508
FHL
Transposition or anteposition
+∞
28.2
27
*
37001
ICD-8 Finland
Refractive errors, Hypermetropia. Hyperopia
+∞
28.2
27
*
H52.3
ICD-10 Finland
Anisometropia and aniseikonia
20.8
27.8
41
20
XCK00
NOMESCO Finland
Perimetry
2.7
27.4
193
736
H52.2
ICD-10 Finland
Astigmatism
11.5
26.9
50
44
F95
ICPC
Strabismus
273.4
26.8
27
*
H50.8
ICD-10 Finland
Other specified strabismus
136.2
25.6
27
*
3780A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]
+∞
24.0
23
*
3783A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia
+∞
22.9
22
*
3680A
ICD-9 Finland
Visual disturbances, Amblyopia ex anopsia
+∞
22.9
22
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.7
22.9
159
600
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
231.7
22.6
23
*
37002
ICD-8 Finland
Refractive errors, Myopia
+∞
21.9
21
*
CEC40
NOMESCO Finland
Resection and advancement of extraocular muscle
+∞
21.9
21
*
H50.4
ICD-10 Finland
Other and unspecified heterotropia
+∞
20.9
20
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
20.7
958
7174
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
20.5
231
1125
ZXA00
NOMESCO Finland
Right side
1.6
20.0
629
4299
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.1
19.0
229
1143
H27.0
ICD-10 Finland
Aphakia
14.9
17.1
28
19
H50.3
ICD-10 Finland
Intermittent heterotropia
+∞
16.7
16
*
3780B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALTERNANS]
+∞
16.7
16
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.0
16.3
205
1044
N05AH03
ATC
olanzapine; systemic
2.1
16.0
179
868
N03AG01
ATC
valproic acid; systemic, rectal
2.1
16.0
183
896
3519
FHL
Other measure in this category
+∞
15.6
15
*
ZXA05
NOMESCO Finland
Left side
1.5
15.2
584
4150
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.8
14.9
96
350
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
9.2
14.7
30
33
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
80.5
14.6
16
*
N03AX09
ATC
lamotrigine; oral
2.2
14.4
148
689
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
42.7
14.1
17
*
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
42.7
14.1
17
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.0
14.0
194
1027
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.2
14.0
74
238
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
30.2
13.9
18
6
N05AH04
ATC
quetiapine; oral
1.6
13.8
438
2976
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
34.2
13.5
17
5
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
11.5
13.3
24
21
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
13.2
458
3173
37405
ICD-8 Finland
Cataract, Traumatica
40.2
13.1
16
*
183
Kela drug reimbursment
Lamotrigin and topiramate
4.7
13.0
43
92
N05AH02
ATC
clozapine; systemic
3.0
12.8
73
245
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
12.1
148
747
N05AA02
ATC
levomepromazine; systemic
2.3
11.8
108
480
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
11.8
374
2533
H53.3
ICD-10 Finland
Other disorders of binocular vision
9.6
11.7
23
24
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
11.3
174
956
N05BA01
ATC
diazepam; systemic, rectal
1.6
11.1
309
2029
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
11.0
348
2356
N03AF02
ATC
oxcarbazepine; oral
2.4
11.0
88
367
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
11.9
10.8
19
16
WX002
NOMESCO Finland
Sedation and analgesia
1.5
10.7
431
3073
3501
FHL
Myotomy or tenotomy
+∞
10.4
10
*
H51.8
ICD-10 Finland
Other specified disorders of binocular movement
+∞
10.4
10
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
10.3
310
2068
N03AF01
ATC
carbamazepine; oral, rectal
2.1
10.3
119
586
ZXA10
NOMESCO Finland
Bilateral
1.5
10.3
400
2830
N06AX11
ATC
mirtazapine; oral
1.3
10.3
768
6117
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
13.1
10.1
17
13
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
10.1
189
1113
H26.4
ICD-10 Finland
After-cataract
1.9
10.0
140
747
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.2
9.9
36
86
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
9.9
627
4860
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
9.9
455
3328
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
9.6
200
1212
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
9.4
235
1498
A06AD11
ATC
lactulose; oral
1.6
9.4
261
1709
37000
ICD-8 Finland
Refractive errors, Astigmatismus
+∞
9.4
9
*
3510
FHL
Cardiac surgery on three or more muscles
+∞
9.4
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
9.4
179
1060
SPAT1101
SPAT
Orthostatic test
2.3
9.3
81
354
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
9.2
262
1726
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.9
9.2
53
183
114
Kela drug reimbursment
Glaucoma
1.8
8.9
148
839
H26.02
ICD-10 Finland
Presenil cataract
2.6
8.9
64
253
N03AX14
ATC
levetiracetam; systemic
2.6
8.9
61
236
N05AX12
ATC
aripiprazole; systemic
2.0
8.8
108
549
S01ED01
ATC
timolol; ophthalmic
2.4
8.8
73
311
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.1
8.7
46
151
37003
ICD-8 Finland
Refractive errors, Anisometropia
50.1
8.7
10
*
3431A
ICD-9 Finland
Infantile cerebral palsy, Hemiplegic
50.1
8.7
10
*
34301
ICD-8 Finland
Cerebral spastic infantile paralysis, Diplegia spastica
27.6
8.5
11
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
90.3
8.4
9
*
N05BA09
ATC
clobazam; oral
4.8
8.4
26
54
3506
FHL
Resection of two muscles
+∞
8.3
8
*
N03AE01
ATC
clonazepam; systemic
1.8
8.3
136
767
N06AB06
ATC
sertraline; oral
1.5
8.3
274
1868
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.6
8.3
57
220
N03AX12
ATC
gabapentin; oral
1.5
8.3
342
2446
H54.4
ICD-10 Finland
Blindness, monocular
10.8
8.3
15
14
R62.0
ICD-10 Finland
Delayed milestone
5.8
8.3
22
38
L28
ICPC
Limited function/disability (L)
1.5
8.2
284
1960
CE2W4
NOMESCO Finland
Eye movement mapping
17.2
8.1
12
7
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
4.8
8.1
25
52
N04AA02
ATC
biperiden; systemic
2.6
8.0
56
219
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
8.0
296
2068
Q12.0
ICD-10 Finland
Congenital cataract
22.1
8.0
11
5
N05CF01
ATC
zopiclone; oral
1.3
8.0
693
5609
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.3
7.9
68
296
L17
ICPC
Foot/toe symptom/complaint
1.3
7.9
541
4229
WX704
NOMESCO Finland
Intubation
1.7
7.9
165
1004
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.8
7.8
119
658
P72
ICPC
Schizophrenia
2.7
7.8
50
185
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
7.8
217
1425
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
7.8
116
635
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.8
528
4122
G40.10
ICD-10 Finland
Simple partial seizures
4.2
7.7
27
64
N05AB03
ATC
perphenazine; systemic, rectal
2.0
7.7
89
446
188
Kela drug reimbursment
Psychosis requiring demanding treatment
3.3
7.6
36
110
F82
ICD-10 Finland
Specific developmental disorder of motor function
6.7
7.6
18
27
S01CA03
ATC
hydrocortisone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
3.6
7.5
32
90
H52.4
ICD-10 Finland
Presbyopia
2.8
7.4
45
163
G91.1
ICD-10 Finland
Obstructive hydrocephalus
6.5
7.4
18
28
N06AB04
ATC
citalopram; systemic
1.3
7.4
495
3855
N05AD01
ATC
haloperidol; systemic
2.3
7.4
64
281
H05.2
ICD-10 Finland
Exophthalmic conditions
8.4
7.3
15
18
N06AA09
ATC
amitriptyline; systemic
1.5
7.3
211
1398
37929
ICD-8 Finland
Blindness, one eye, specifically defined
+∞
7.3
7
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
+∞
7.3
7
*
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
7.3
7
*
H50.39
ICD-10 Finland
Intermittent heterotropia
+∞
7.3
7
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.8
7.3
43
153
N03AX11
ATC
topiramate; oral
2.2
7.3
72
338
87011
ICD-8 Finland
Open wound of eye and orbit, Perforans oculi, Complicata
15.8
7.2
11
7
N05AX08
ATC
risperidone; systemic
1.6
7.2
162
1007
SPAT1240
SPAT
Therapeutic discussion
1.5
7.2
269
1886
R03AC02
ATC
salbutamol; inhalant
1.2
7.2
1317
11657
37404
ICD-8 Finland
Cataract, Secundaria
30.1
7.1
9
*
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
6.6
7.1
17
26
N06AX16
ATC
venlafaxine; oral
1.4
7.1
338
2486
WX702
NOMESCO Finland
Supraglottic ventilation device
1.8
7.0
122
705
A10BA02
ATC
metformin; oral
1.3
6.9
515
4075
H54.7
ICD-10 Finland
Unspecified visual loss
4.8
6.8
21
44
M41.9
ICD-10 Finland
Scoliosis, unspecified
3.1
6.8
35
115
34300
ICD-8 Finland
Cerebral spastic infantile paralysis, Hemiplegia spastica
40.1
6.8
8
*
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
40.1
6.8
8
*
SPAT1234
SPAT
Support of social functional capacity
1.9
6.7
94
507
37520
ICD-8 Finland
Glaucoma, Secondary
22.6
6.7
9
*
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
6.7
189
1250
A46
ICD-10 Finland
Erysipelas
1.4
6.6
263
1872
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.6
504
4001
N02BE01
ATC
paracetamol; systemic, rectal
1.3
6.6
2237
21072
F20.32
ICD-10 Finland
Undifferentiated schizophrenia stable periodically
8.7
6.5
13
15
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
6.5
90
482
H54.5
ICD-10 Finland
Severe visual impairment, monocular
5.3
6.5
18
34
H50.50
ICD-10 Finland
Alternating hyperphoria
70.0
6.4
7
*
XA800
NOMESCO Finland
Neuropsychological investigation
1.8
6.3
95
525
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
6.3
361
2736
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
6.3
100
560
S01EX03
ATC
NA
2.7
6.3
39
145
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
6.3
162
1044
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
18.0
6.3
9
5
A28
ICPC
Limited function/disability NOS
1.5
6.3
231
1620
3782A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS CONVERGENS INTERMITTENS]
+∞
6.2
6
*
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
6.2
6
*
3671A
ICD-9 Finland
Disorders of refraction and accommodation, Myopia
+∞
6.2
6
*
ZSC00
NOMESCO Finland
Procedure related to previous procedure classified in chapter C
+∞
6.2
6
*
78112
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Nystagmus
+∞
6.2
6
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
6.2
692
5764
N03AX16
ATC
pregabalin; oral
1.3
6.2
496
3958
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.2
6.2
877
7512
F20
ICD-10 Finland
Schizophrenia
3.9
6.2
23
59
WX110
NOMESCO Finland
Local anesthesy
1.2
6.1
1799
16598
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
6.1
187
1257
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
12.5
6.1
10
8
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
6.0
192
1303
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
98
393
2.54
16.19
5.4
5.6
383.6
368.1
umol/l
0.40
87
346
376
2458
1.60
15.01
8.1
8.0
1.6
1.1
mmol/l
1.97
286
1898
1093
8882
1.35
13.62
3.4
3.2
32.6
34.0
u/l
0.23
1032
8457
318
2043
1.62
13.60
8.5
8.7
123.3
122.6
g/l
0.21
305
1969
368
2449
1.57
13.56
8.2
8.0
5.2
5.1
kpa
1.56
345
2337
368
2450
1.57
13.54
8.2
8.0
12.2
12.8
kpa
1.07
345
2338
1377
11786
1.29
11.21
6.6
6.5
1.2
1.2
mmol/l
1.10
1175
10021
704
5495
1.36
11.00
4.5
3.7
1.0
1.0
kg/l
0.04
90
796
876
7067
1.33
10.97
2.2
2.1
208.9
214.0
u/l
0.04
815
6679
216
1339
1.66
10.64
8.9
7.0
24.8
24.5
mmol/l
0.52
204
1246
2142
19498
1.29
10.37
6.8
7.3
78.5
77.0
u/l
0.81
2029
18430
1457
12659
1.28
10.20
3.9
3.4
0.0
0.0
estimate
0.80
237
2352
1453
12682
1.27
9.57
5.1
4.6
0.0
0.0
estimate
0.50
247
2415
1239
10615
1.27
9.52
6.3
5.9
1.2
1.2
mmol/l
0.92
1137
9688
1464
12805
1.26
9.42
3.9
3.4
0.0
0.0
estimate
0.17
242
2341
1629
14428
1.26
9.42
5.1
4.6
6.8
6.6
mmol/l
2.11
1523
13417
2450
22825
1.30
9.22
17.7
15.1
13.7
13.6
%
1.59
2410
22350
1118
9497
1.27
9.11
1.9
1.9
98.0
96.6
pmol/l
0.43
580
5014
1205
10338
1.26
9.01
4.5
4.8
35.9
36.1
g/l
0.62
1124
9665
2816
26818
1.39
8.81
16.0
13.6
139.7
139.7
mmol/l
0.24
2757
26145
2817
26919
1.37
7.84
15.9
13.7
4.0
3.9
mmol/l
0.21
2753
26191
180
1168
1.57
7.42
9.1
11.1
—
—
—
0
0
139
847
1.67
7.40
5.3
5.2
1.7
1.6
%
0.34
129
786
368
2765
1.37
7.13
8.2
7.4
104.7
104.6
mmol/l
0.20
363
2708
336
2494
1.39
7.01
1.9
1.7
—
—
—
0
0
204
1379
1.51
7.01
10.2
10.1
0.7
0.7
%
0.64
204
1368
337
2506
1.38
6.96
2.0
2.1
379.1
371.2
nmol/l
0.32
318
2306
1022
8806
1.23
6.90
3.3
3.2
38.5
48.3
ng/l
0.44
593
5231
2244
20946
1.23
6.82
4.6
4.0
14.7
14.6
pmol/l
1.37
2102
19400
202
1381
1.49
6.59
10.2
10.0
1.6
1.4
%
0.95
202
1372
2088
19402
1.22
6.37
4.2
3.9
11.2
10.9
mm/h
0.46
1965
18153
252
1810
1.43
6.37
2.2
2.3
7.5
7.1
ug/l
0.09
215
1616
327
2457
1.37
6.34
1.9
1.7
—
—
—
0
0
1127
9914
1.21
6.01
4.0
3.5
—
—
—
0
0
198
1375
1.47
6.00
10.5
10.2
93.4
94.2
%
1.18
198
1368
109
663
1.67
5.91
6.5
4.1
3.9
3.9
mmol/l
0.67
104
620
545
4456
1.27
5.73
3.6
3.4
381.0
467.8
ng/l
0.24
395
3087
49
233
2.12
5.70
1.3
1.4
11.5
12.3
mmol/l
—
10
54
905
7830
1.22
5.65
2.6
2.5
54.9
57.0
u/l
0.72
832
7276
210
2896
0.71
5.58
4.6
4.0
31.0
31.9
%
0.61
148
2056
1660
15201
1.19
5.55
10.6
9.2
4.1
4.0
e9/l
1.32
1456
13350
622
5188
1.25
5.49
1.5
1.5
20.0
20.7
nmol/l
0.66
549
4515
1421
12852
1.19
5.44
5.5
6.1
11.1
11.3
umol/l
0.16
1346
12204
359
2804
1.32
5.37
7.6
6.2
—
—
—
0
0
781
6699
1.22
5.27
4.5
3.7
0.0
0.0
estimate
1.49
238
2349
98
602
1.65
5.16
1.8
1.6
1964.5
1246.4
e6/l
0.30
83
484
98
602
1.65
5.16
1.7
1.6
11.4
31.1
e6/l
1.01
78
461
163
1128
1.47
5.07
9.9
10.9
24.5
24.3
mmol/l
0.53
147
1065
20
66
3.04
4.94
2.6
2.2
18.8
16.2
umol/l
0.39
20
66
599
5032
1.23
4.92
2.5
2.5
5.2
6.4
e6/l
1.69
526
4391
2781
26836
1.26
4.91
14.3
12.5
22.4
21.8
mg/l
0.35
2228
20914
1190
10682
1.18
4.79
2.4
2.2
74.2
75.7
nmol/l
1.10
1108
9812
1797
16718
1.17
4.55
4.9
4.0
1821.9
1745.1
e6/l
0.02
34
206
160
1132
1.43
4.47
1.9
1.9
—
—
—
0
0
477
3951
1.24
4.44
1.7
1.7
1200.9
1173.4
nmol/l
0.28
385
3051
273
2109
1.32
4.44
4.2
4.1
5.9
5.8
kpa
0.35
266
2049
767
6670
1.20
4.39
1.7
1.6
1.4
1.4
mmol/l
0.07
671
5731
461
3823
1.24
4.25
3.2
3.8
0.8
0.8
mmol/l
0.23
436
3603
243
1860
1.33
4.22
1.3
1.3
108.7
204.8
u/ml
4.56
227
1729
381
3095
1.26
4.21
5.4
5.9
1.1
1.1
mmol/l
0.35
361
2889
255
1972
1.32
4.13
7.9
7.8
1.3
1.4
mmol/l
0.42
240
1893
2561
24605
1.20
4.12
5.3
4.7
3.1
2.0
mu/l
0.64
2414
22943
269
2098
1.31
4.10
4.1
4.2
1.9
1.9
mmol/l
0.14
220
1690
438
3628
1.24
4.08
1.9
1.8
—
—
—
0
0
93
601
1.56
4.06
1.7
1.4
3.7
3.7
mmol/l
0.10
87
564
916
8140
1.17
4.03
2.9
3.3
2.4
2.4
mmol/l
0.01
810
7256
834
7355
1.18
4.02
3.4
3.3
7.4
7.8
mmol/l
1.32
716
6303
222
1696
1.33
3.93
2.8
2.9
118.6
182.0
ng/l
3.26
197
1522
570
4872
1.21
3.90
1.3
1.3
27.5
28.1
iu/ml
0.03
186
1530
778
6838
1.18
3.89
3.9
4.0
12.6
8.9
mg/mmol
0.63
494
4364
2468
23680
1.18
3.82
5.7
5.0
39.6
39.0
mmol/mol
2.32
2327
22239
479
4040
1.22
3.75
2.6
2.6
1.0
1.3
e6/l
0.97
276
2247
757
6661
1.18
3.72
3.0
3.0
0.4
0.4
e6/l
0.12
582
4975
225
1746
1.31
3.59
4.2
3.7
5.0
4.7
kpa
0.95
218
1689
89
595
1.51
3.39
4.8
4.4
8.5
8.6
kpa
0.32
84
556
663
5814
1.18
3.37
3.2
3.0
1042.9
1167.8
ng/l
0.47
558
4868
1341
12384
1.14
3.36
6.7
6.2
2.8
2.8
%
0.04
1260
11593
31
157
1.98
3.19
1.1
1.1
1.1
1.1
u/l
0.10
14
76
25
117
2.15
3.16
4.0
2.2
142.7
157.3
nmol/l
0.42
20
102
127
923
1.39
3.14
5.1
3.8
54.3
50.4
%
0.96
127
912
250
2004
1.27
3.13
2.5
2.7
10.6
10.5
g/l
0.11
231
1843
353
2941
1.22
3.13
2.6
3.0
9.0
7.6
umol/l
0.34
295
2550
1314
12164
1.14
3.10
3.1
2.8
105.4
106.6
ug/l
0.06
1237
11424
41
231
1.78
3.08
1.2
1.2
38.2
39.7
mg/l
0.10
33
189
1370
12722
1.13
3.07
6.5
6.0
56.9
56.6
%
0.50
1288
11972
40
225
1.79
3.02
1.1
1.1
232.8
266.6
mg/l
0.45
35
193
227
1817
1.27
2.90
3.6
3.3
4.4
4.5
pmol/l
0.64
209
1618
433
3709
1.19
2.89
2.5
2.4
12.9
13.9
umol/l
2.04
406
3449
1384
12902
1.13
2.85
6.7
6.2
28.7
28.9
%
0.42
1297
12106
101
725
1.41
2.73
2.0
1.9
4.0
4.3
iu/l
0.11
44
271
38
218
1.75
2.72
1.1
1.1
—
—
—
0
0
41
243
1.70
2.63
1.5
1.5
—
—
—
0
0
561
4953
1.16
2.60
1.7
1.6
77236226.5
32772941.6
pmol/l
0.55
492
4220
8
20
4.01
2.56
1.5
1.3
1.5
1.0
mg/l
—
8
12
8
20
4.01
2.56
1.5
1.3
1.9
4.6
mg/l
—
8
10
8
20
4.01
2.56
1.5
1.3
0.6
3.5
mg/l
—
8
13
8
20
4.01
2.56
1.5
1.3
0.2
1.0
mg/l
—
8
11
8
20
4.01
2.56
1.5
1.3
0.6
2.1
mg/l
—
8
12
8
20
4.01
2.56
1.5
1.3
1.0
4.4
mg/l
—
8
11
12
45
2.67
2.45
5.3
1.9
—
—
—
0
0
317
2686
1.20
2.41
21.3
20.8
1.2
1.3
inr
0.02
44
401
150
1174
1.29
2.34
1.1
1.1
1.3
0.9
u/ml
—
6
15
128
982
1.32
2.32
3.7
3.3
0.7
0.7
%
0.19
123
948
155
1221
1.28
2.31
1.4
1.6
358.6
284.5
mu/l
1.52
141
1098
676
6104
1.14
2.26
2.4
2.2
2.8
2.9
mg/l
0.34
597
5226
3063
30227
1.26
2.24
21.6
18.2
258.6
257.4
e9/l
0.44
2992
29551
138
1077
1.29
2.22
1.3
1.3
0.3
0.9
u/ml
1.53
11
91
25
135
1.86
2.22
3.8
2.9
146.0
179.9
umol/l
0.25
17
73
3066
30264
1.26
2.21
21.7
18.3
136.0
136.1
g/l
0.21
3029
29895
3065
30254
1.26
2.20
21.6
18.2
4.5
4.5
e12/l
0.75
2987
29518
391
3402
1.17
2.20
2.6
2.4
2.4
2.4
g/l
0.94
361
3170
168
1346
1.26
2.20
1.7
1.5
—
—
—
0
0
363
3143
1.17
2.17
2.6
2.5
21.9
23.8
%
1.86
290
2718
72
510
1.42
2.16
2.7
3.1
32.5
36.5
umol/l
0.65
62
440
6
14
4.29
2.15
1.0
1.1
9.6
7.8
%
—
6
14
6
14
4.29
2.15
1.0
1.1
34.5
37.4
%
—
6
14
2616
25504
1.14
2.15
16.4
13.2
40.2
40.2
%
0.13
1956
19867
26
144
1.81
2.14
1.1
1.1
—
7.6
nmol/l
—
0
26
3065
30262
1.26
2.13
21.7
18.2
6.8
6.7
e9/l
1.10
2989
29517
520
4634
1.15
2.12
1.4
1.3
2.8
10.0
u/ml
8.67
198
1901
76
551
1.39
2.02
1.8
1.8
—
—
—
0
0
429
3786
1.15
2.01
2.7
2.8
3.9
3.0
e6/l
0.55
222
2011
2592
25283
1.13
2.01
4.5
4.0
5.9
5.8
mmol/l
1.75
2416
23437
471
4194
1.14
1.95
2.7
2.9
2.4
2.4
mmol/l
0.21
402
3683
65
462
1.42
1.95
1.4
1.3
—
—
—
0
0
65
462
1.42
1.95
1.4
1.3
—
—
—
0
0
237
1999
1.20
1.94
6.6
8.3
8.6
8.8
mmol/l
0.17
222
1920
6
16
3.75
1.93
1.0
1.1
—
—
—
0
0
51
347
1.48
1.92
1.3
1.2
—
—
—
0
0
1958
18838
1.10
1.92
3.3
3.0
47.0
44.2
u/l
0.43
1864
17848
258
3013
0.84
1.88
1.8
1.7
—
—
—
0
0
23
129
1.79
1.85
1.7
1.7
—
—
—
0
0
95
725
1.32
1.85
1.2
1.2
2.6
7.2
u/ml
1.60
12
123
81
605
1.35
1.82
1.2
1.2
50.0
41.1
u/ml
0.23
14
65
103
798
1.30
1.81
1.1
1.1
—
—
—
0
0
233
1977
1.19
1.80
2.7
2.5
67.0
70.9
ml/min/173m2
0.61
91
751
287
2480
1.17
1.79
3.4
4.5
253.8
243.9
u/l
0.19
267
2354
10
41
2.44
1.75
1.1
1.0
—
—
—
0
0
139
1123
1.25
1.75
2.0
2.0
37.7
39.8
u/l
0.61
128
1019
103
803
1.29
1.74
1.1
1.1
—
—
—
0
0
277
2399
1.17
1.70
2.4
2.4
33.5
59.7
u/l
0.72
227
2070
214
1814
1.19
1.69
1.3
1.4
32.6
28.6
iu/l
0.92
175
1552
707
6509
1.11
1.69
2.3
2.5
1931.8
4243.3
umol/l
1.55
611
5751
2902
28579
1.15
1.68
10.4
9.6
27.8
26.7
u/l
1.45
2824
27751
65
876
0.74
1.67
1.4
1.4
—
—
—
0
0
65
875
0.74
1.66
1.4
1.4
—
—
—
0
0
73
546
1.34
1.66
3.0
3.3
24.8
24.8
mmol/l
0.02
61
486
65
874
0.74
1.65
1.4
1.4
—
—
—
0
0
92
713
1.30
1.64
1.3
1.2
6.2
7.2
u/ml
0.08
11
76
65
872
0.74
1.63
1.4
1.4
—
—
—
0
0
109
864
1.27
1.63
1.4
1.8
1.3
1.2
g/l
2.40
99
814
89
688
1.30
1.62
2.4
2.9
—
—
—
0
0
414
3708
1.13
1.59
2.2
1.8
1.4
1.4
%
0.74
387
3332
137
1667
0.81
1.59
1.5
1.5
—
—
—
0
0
6
20
3.00
1.58
1.0
1.0
—
—
—
0
0
58
422
1.38
1.57
1.4
1.5
—
—
—
0
0
105
833
1.27
1.57
1.4
1.8
0.2
0.2
g/l
1.04
95
784
145
1196
1.22
1.54
4.0
4.6
24.5
24.1
mmol/l
0.75
129
1091
24
145
1.66
1.54
1.1
1.1
—
—
—
0
0
177
1493
1.20
1.50
4.2
4.1
5.2
5.2
kpa
0.11
167
1398
131
1073
1.23
1.50
1.3
1.3
204.9
226.0
miu/ml
0.24
47
535
20
116
1.73
1.48
1.3
1.4
—
—
—
0
0
29
186
1.56
1.48
2.8
1.6
—
—
—
0
0
104
835
1.25
1.43
1.1
1.1
1.1
4.8
u/ml
2.61
17
122
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
156
1.61
1.43
1.1
1.1
—
—
—
0
0
72
553
1.31
1.41
1.2
1.2
14.8
3.8
u/ml
—
5
42
9
40
2.25
1.40
1.1
1.1
—
—
—
0
0
28
181
1.55
1.40
1.1
1.4
82803.7
84745.3
e6/l
0.01
19
107
10
46
2.18
1.40
1.1
1.2
—
—
—
0
0
74
950
0.77
1.39
1.4
1.5
—
—
—
0
0
7
29
2.42
1.39
1.1
1.2
1.4
1.8
umol/24h
—
7
29
31
206
1.51
1.37
1.1
1.4
2736.8
2678.6
e6/l
0.02
24
144
28
420
0.66
1.37
1.0
1.1
0.0
0.3
u/ml
—
10
102
695
6462
1.10
1.36
1.3
1.3
1.1
1.6
u/ml
1.11
201
1749
103
833
1.24
1.35
2.8
2.0
1.5
2.0
ug/l
0.36
95
751
20
120
1.67
1.34
1.3
1.4
—
—
—
0
0
641
5943
1.10
1.33
1.8
1.9
1.1
1.1
mg/l
0.12
477
4427
12
61
1.97
1.32
1.2
1.4
52.0
31.3
%
—
5
41
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
8
35
2.29
1.26
1.3
1.8
73.8
104.6
ng/l
—
8
35
559
6031
0.91
1.22
2.2
2.2
—
—
—
0
0
86
691
1.25
1.22
1.6
1.6
—
—
—
0
0
270
2400
1.14
1.22
2.6
2.8
1.7
1.8
%
0.53
242
2143
49
365
1.35
1.21
1.4
1.4
—
—
—
0
0
390
3547
1.11
1.20
2.1
2.4
29.5
29.7
s
0.30
380
3424
77
961
0.80
1.19
2.2
1.9
—
—
—
0
0
29
197
1.48
1.19
1.8
1.6
—
—
—
0
0
6
26
2.31
1.18
1.2
1.1
—
—
—
0
0
8
38
2.11
1.18
1.1
1.3
—
—
—
0
0
74
587
1.27
1.17
1.6
1.9
190.4
200.6
pmol/l
0.45
68
553
16
94
1.71
1.17
1.3
1.1
—
—
—
0
0
43
316
1.37
1.16
1.3
1.4
—
—
—
0
0
0
34
0.00
1.16
0.0
2.1
—
—
—
0
0
45
334
1.35
1.15
1.4
1.7
—
—
—
0
0
374
4101
0.90
1.14
2.3
2.1
—
—
—
0
0
74
590
1.26
1.13
1.5
1.7
—
—
—
0
0
59
457
1.30
1.13
1.6
1.7
—
—
—
0
0
7
30
2.34
1.12
1.0
1.0
—
—
—
0
0
8
40
2.00
1.12
1.1
1.1
—
—
—
0
0
38
276
1.38
1.11
1.0
1.1
—
—
—
0
0
165
1430
1.16
1.08
4.3
4.1
1.7
1.6
mmol/l
0.14
128
1073
64
505
1.27
1.08
2.1
2.3
135.4
131.4
g/l
0.68
49
376
53
409
1.30
1.06
3.5
3.0
7.4
7.3
mmol/l
0.11
53
398
195
1716
1.15
1.05
2.2
2.6
66.3
66.8
g/l
0.34
182
1579
67
535
1.26
1.03
1.5
1.4
21.1
26.2
u/l
0.75
55
440
68
544
1.26
1.03
1.6
1.4
108.6
114.4
u/ml
0.23
26
105
42
553
0.76
1.02
2.2
2.3
0.8
0.8
nmol/l
0.30
36
472
337
3690
0.90
1.02
2.3
2.0
—
—
—
0
0
190
1674
1.14
1.01
1.5
1.6
—
—
—
0
0
56
439
1.28
1.01
3.4
2.9
1.6
1.5
mmol/l
0.23
56
424
5
107
0.47
1.01
2.4
2.5
—
—
—
0
0
263
2367
1.12
1.00
2.0
1.9
—
—
—
0
0
9
48
1.88
1.00
1.0
1.2
—
—
—
0
0
131
1125
1.17
0.99
1.5
1.5
—
—
—
0
0
0
29
0.00
0.97
0.0
1.0
—
5.2
—
0
19
15
92
1.63
0.97
1.1
1.2
—
—
—
0
0
19
124
1.54
0.96
1.3
1.5
9.6
13.7
u/l
3.33
19
119
101
851
1.19
0.96
1.5
2.0
—
—
—
0
0
194
1722
1.13
0.94
3.8
3.8
89.0
80.8
ng/l
0.54
174
1513
31
225
1.38
0.94
1.4
1.4
3405.9
98332.6
e6/l
1.41
23
155
638
6008
1.08
0.94
1.7
1.6
—
—
—
0
0
57
453
1.26
0.94
1.2
1.3
4.6
3.9
u/ml
0.08
24
155
73
597
1.23
0.94
1.3
1.3
245.6
260.2
u/ml
0.20
46
369
87
725
1.21
0.93
1.8
2.3
10.9
10.4
g/l
0.39
73
620
34
454
0.75
0.93
1.0
1.1
3.8
4.0
u/ml
0.04
19
178
76
625
1.22
0.93
1.3
1.3
—
—
—
0
0
12
70
1.72
0.92
2.8
2.8
—
—
—
0
0
12
70
1.72
0.92
2.8
2.8
—
—
—
0
0
6
28
2.14
0.91
1.2
1.1
—
—
—
0
0
71
581
1.23
0.91
1.5
1.7
—
—
—
0
0
20
135
1.48
0.89
1.1
1.0
747.8
754.0
ng/l
0.02
12
88
38
495
0.76
0.88
1.1
1.1
3.5
4.9
u/ml
0.40
19
178
70
576
1.22
0.86
1.7
1.8
20146.7
12455.6
e6/l
0.49
52
416
20
136
1.47
0.86
1.1
1.0
282.4
300.1
ng/l
0.12
12
91
94
1105
0.85
0.86
1.5
1.4
—
—
—
0
0
203
1823
1.12
0.84
2.4
2.2
12.7
12.7
nmol/l
0.03
183
1617
18
121
1.49
0.82
1.2
1.2
—
—
—
0
0
20
138
1.45
0.81
1.1
1.0
39.3
43.2
ng/l
0.18
12
88
544
5129
1.07
0.79
1.5
1.5
—
—
—
0
0
9
148
0.61
0.79
1.6
1.9
—
—
—
0
0
7
125
0.56
0.77
1.4
1.6
—
—
—
0
0
28
208
1.35
0.77
3.6
1.8
34.5
19.7
ug/l
0.47
28
203
7
126
0.55
0.77
1.4
1.6
—
—
—
0
0
102
881
1.16
0.76
2.5
2.8
96.1
92.8
%
0.62
90
824
0
28
0.00
0.76
0.0
2.3
—
—
—
0
0
15
99
1.52
0.75
1.0
1.1
—
—
—
0
0
10
60
1.67
0.72
1.7
1.7
—
—
—
0
0
29
220
1.32
0.71
1.3
1.6
—
—
—
0
0
29
220
1.32
0.71
1.3
1.6
—
—
—
0
0
29
220
1.32
0.71
1.3
1.6
—
—
—
0
0
105
1199
0.87
0.70
2.0
1.7
5.7
3.9
mg/l
0.38
76
835
86
740
1.17
0.69
1.9
2.3
2.9
3.1
g/l
1.87
68
577
378
3537
1.08
0.69
2.1
2.5
107.5
119.6
ug/g
0.30
295
2844
91
788
1.16
0.68
1.8
2.2
3.6
3.8
g/l
1.11
65
564
11
69
1.60
0.68
1.5
1.4
37.2
49.5
%
0.45
11
60
91
789
1.16
0.67
1.8
2.2
—
—
—
0
0
91
789
1.16
0.67
1.8
2.2
6.9
7.3
g/l
1.60
69
594
17
238
0.71
0.67
1.1
1.1
—
—
—
0
0
17
119
1.43
0.66
2.8
2.3
34.8
86.2
ug/l
0.36
17
107
22
162
1.36
0.66
3.1
1.7
—
—
—
0
0
104
913
1.14
0.65
1.7
1.7
—
—
—
0
0
72
615
1.17
0.65
1.2
1.3
—
—
—
0
0
84
967
0.87
0.64
1.7
1.7
—
—
—
0
0
13
189
0.69
0.63
2.0
2.1
0.6
1.7
u/field
—
8
86
1236
12012
1.05
0.63
4.0
3.9
—
—
—
0
0
21
280
0.75
0.62
5.1
4.7
12.9
81.6
u/ml
—
6
80
70
599
1.17
0.62
2.0
2.2
0.0
0.0
g/l
0.89
64
555
6
101
0.59
0.62
1.3
2.0
—
—
—
0
0
6
101
0.59
0.62
1.3
2.0
—
—
—
0
0
6
102
0.59
0.62
1.3
2.0
—
—
—
0
0
12
80
1.50
0.59
1.1
1.1
—
—
—
0
0
12
80
1.50
0.59
1.1
1.1
—
—
—
0
0
495
4705
1.06
0.59
4.1
3.7
21.8
21.2
%
0.47
219
2010
84
733
1.15
0.59
5.9
5.3
1.4
1.4
mg/l
0.15
76
692
27
210
1.29
0.58
4.1
2.2
—
—
—
0
0
75
862
0.87
0.58
2.2
1.8
—
—
—
0
0
6
36
1.67
0.56
3.7
2.3
—
—
—
0
0
31
247
1.26
0.56
1.2
1.4
—
—
—
0
0
14
98
1.43
0.56
1.0
1.0
—
—
—
0
0
5
87
0.57
0.56
2.6
2.1
—
—
—
0
0
20
263
0.76
0.56
1.2
1.1
—
—
—
0
0
81
710
1.14
0.55
2.5
2.2
9.5
11.4
mg/l
1.26
76
659
19
142
1.34
0.54
1.1
1.1
1810.3
1565.6
miu/ml
0.35
19
142
205
1896
1.09
0.54
2.4
3.6
1.2
1.2
mmol/l
0.38
175
1648
103
920
1.12
0.53
1.3
1.3
—
—
—
0
0
617
5923
1.05
0.53
4.4
4.3
2.7
2.3
ug/l
0.51
552
5345
104
930
1.12
0.53
1.6
1.9
1.5
1.5
g/l
0.09
91
818
27
214
1.26
0.52
1.5
1.4
1.3
1.4
nmol/l
0.17
21
192
172
1582
1.09
0.52
1.1
1.0
—
—
—
0
0
13
180
0.72
0.51
1.3
1.8
—
—
—
0
0
13
92
1.41
0.50
1.2
1.4
—
—
—
0
0
13
92
1.41
0.50
1.2
1.4
—
—
—
0
0
51
435
1.18
0.50
1.1
1.1
121.9
117.0
%
0.47
41
403
244
2281
1.08
0.50
2.2
2.4
0.2
0.2
g/l
0.12
232
2145
36
297
1.21
0.50
1.2
1.2
—
—
—
0
0
89
793
1.13
0.49
2.4
2.9
168.0
179.6
%
0.74
81
754
12
84
1.43
0.49
1.1
1.1
—
—
—
0
0
10
144
0.69
0.49
1.4
1.6
—
—
—
0
0
7
107
0.65
0.48
1.1
1.2
—
—
—
0
0
7
46
1.52
0.48
1.1
1.5
—
—
—
0
0
26
208
1.25
0.48
2.3
2.7
—
—
—
0
0
2514
24899
1.04
0.46
12.1
11.1
86.9
86.0
ml/min/173m2
1.24
2012
20517
25
200
1.25
0.46
1.2
1.2
—
—
—
0
0
25
201
1.25
0.45
1.2
1.2
—
—
—
0
0
14
186
0.75
0.44
1.2
1.3
—
—
—
0
0
38
321
1.19
0.43
1.1
1.1
96.1
96.2
%
0.01
31
306
26
211
1.23
0.43
1.3
1.1
—
—
—
0
0
26
211
1.23
0.43
1.3
1.1
—
—
—
0
0
61
536
1.14
0.43
4.1
6.3
349.0
456.6
iu/ml
—
7
75
63
555
1.14
0.43
2.0
2.3
0.0
0.0
g/l
0.00
57
515
201
1880
1.07
0.43
1.8
1.9
—
—
—
0
0
11
78
1.41
0.43
2.5
4.1
—
—
—
0
0
21
167
1.26
0.41
1.3
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
5.2
—
—
—
0
0
49
426
1.15
0.41
1.4
1.8
—
—
—
0
0
16
123
1.30
0.40
2.4
2.0
1.7
1.9
umol/l
0.36
16
115
63
559
1.13
0.40
2.0
2.3
0.0
0.0
g/l
0.00
57
516
33
278
1.19
0.40
1.5
1.7
52.3
60.5
%
0.58
22
173
53
465
1.14
0.39
1.1
1.1
1.2
2.8
u/ml
2.38
27
233
84
759
1.11
0.39
1.8
2.5
2864.1
390.6
ug/l
0.50
75
707
100
912
1.10
0.39
1.4
1.4
13.2
10.1
u/l
0.95
77
738
26
214
1.22
0.39
1.3
1.1
—
—
—
0
0
26
214
1.22
0.39
1.3
1.1
—
—
—
0
0
26
214
1.22
0.39
1.3
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
54
475
1.14
0.39
2.1
2.5
16.9
16.6
%
0.26
32
238
17
215
0.79
0.39
2.6
3.1
67.8
55.4
%
—
8
152
11
80
1.38
0.38
1.1
1.1
—
—
—
0
0
47
410
1.15
0.38
1.2
1.1
—
—
—
0
0
5
36
1.39
0.38
1.0
2.4
—
—
—
0
0
29
342
0.85
0.35
1.1
1.3
—
0.4
nmol/l
—
0
24
1994
19714
1.03
0.35
3.3
3.3
—
—
—
0
0
30
352
0.85
0.35
1.9
3.5
1.3
1.4
%
0.08
20
292
47
414
1.14
0.34
2.4
2.6
5.0
5.8
umol/l
0.39
36
305
187
1763
1.06
0.34
1.3
1.3
38.6
48.0
au/ml
—
6
77
16
200
0.80
0.34
1.1
1.2
—
—
—
0
0
68
614
1.11
0.34
1.9
2.2
39.2
38.0
g/l
1.18
60
535
38
330
1.15
0.34
1.3
1.6
—
—
—
0
0
25
209
1.20
0.34
4.2
3.8
—
—
—
0
0
55
615
0.89
0.33
1.5
1.5
—
—
—
0
0
50
444
1.13
0.33
1.3
1.3
3.7
5.1
u/ml
0.53
24
192
6
89
0.67
0.33
1.2
1.2
—
—
—
0
0
90
828
1.09
0.32
1.3
1.1
—
—
—
0
0
11
83
1.33
0.32
1.1
1.1
—
—
—
0
0
16
197
0.81
0.31
1.1
1.2
—
—
—
0
0
57
514
1.11
0.30
3.5
3.4
27.5
24.0
mg/l
0.22
36
324
2606
26222
0.97
0.30
4.3
4.0
1.4
1.5
mmol/l
4.65
2456
24620
148
1393
1.07
0.30
2.5
2.2
1416.8
5151.8
u/l
3.04
51
548
24
203
1.18
0.29
1.8
1.5
37.9
33.9
%
0.20
19
119
58
640
0.90
0.29
1.2
1.2
—
—
—
0
0
202
1922
1.05
0.29
2.4
2.4
17.8
21.5
au/ml
0.33
14
140
75
689
1.09
0.28
1.1
1.1
1.1
1.9
u/ml
0.67
35
281
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
61
669
0.91
0.28
3.1
3.8
0.3
0.3
u/ml
0.02
32
376
167
1585
1.06
0.27
1.4
1.4
—
—
—
0
0
26
224
1.16
0.27
4.0
2.2
15.2
12.1
%
0.56
19
111
5
73
0.68
0.26
1.0
1.4
—
—
—
0
0
26
299
0.87
0.26
1.4
1.5
—
—
—
0
0
135
1278
1.06
0.25
1.7
1.6
—
—
—
0
0
53
580
0.91
0.24
1.1
1.1
2.0
2.3
u/ml
0.05
12
144
120
1133
1.06
0.24
1.4
1.4
—
—
—
0
0
26
297
0.87
0.24
1.4
1.5
—
—
—
0
0
43
475
0.90
0.24
1.3
1.5
—
—
—
0
0
73
678
1.08
0.23
2.1
2.4
0.8
1.0
g/l
0.15
66
595
26
296
0.88
0.23
1.4
1.5
—
—
—
0
0
15
179
0.84
0.23
4.4
2.2
—
—
—
0
0
32
285
1.12
0.22
1.2
1.7
—
—
—
0
0
13
157
0.83
0.22
1.5
1.6
1.1
6.9
u/l
—
7
81
29
257
1.13
0.22
4.3
4.2
6.4
7.1
mmol/l
0.88
19
221
5
42
1.19
0.21
1.6
6.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
132.2
—
0
6
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
5898.0
—
0
5
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
5.1
—
388.2
—
0
12
0
12
0.00
0.21
0.0
1.6
—
10.8
—
0
5
27
304
0.89
0.21
1.4
1.5
—
—
—
0
0
249
2407
1.04
0.21
3.3
3.0
—
—
—
0
0
39
354
1.10
0.20
2.8
3.2
0.8
0.8
nmol/l
0.03
34
277
10
123
0.81
0.20
1.5
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
59
635
0.93
0.20
1.4
1.4
—
—
—
0
0
21
183
1.15
0.20
1.1
1.2
1.1
1.0
ratio
—
6
70
13
108
1.20
0.20
2.2
3.8
—
—
—
0
0
9
111
0.81
0.20
1.1
1.2
—
—
—
0
0
339
3481
0.97
0.19
2.8
2.8
0.8
0.7
ug/l
0.47
214
2086
92
870
1.06
0.19
1.5
1.3
—
—
—
0
0
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
27
301
0.90
0.18
1.4
1.5
—
—
—
0
0
20
175
1.14
0.18
1.3
1.6
—
—
—
0
0
104
990
1.05
0.18
5.3
4.3
24.8
24.8
mmol/l
0.09
98
928
11
91
1.21
0.17
1.0
1.3
—
—
—
0
0
2627
26370
0.98
0.17
4.4
4.0
4.7
4.8
mmol/l
3.41
2484
24879
8
69
1.16
0.16
1.3
1.1
—
—
—
0
0
8
69
1.16
0.16
1.3
1.1
98.6
96.5
%
—
8
69
27
297
0.91
0.15
1.3
1.5
—
—
—
0
0
2520
25298
0.98
0.15
3.9
3.6
1.3
1.3
mmol/l
1.30
2369
23650
7
88
0.79
0.14
1.3
3.2
—
—
—
0
0
7
89
0.79
0.14
1.4
2.2
—
32342.7
—
0
14
43
460
0.93
0.14
1.0
1.1
3.7
18035.6
iu/ml
—
6
130
39
364
1.07
0.13
1.2
1.2
—
—
—
0
0
46
489
0.94
0.13
1.5
1.6
—
—
—
0
0
75
785
0.95
0.13
2.4
3.7
248.3
1931.5
u/ml
0.72
63
672
20
221
0.90
0.12
1.3
1.5
—
—
—
0
0
12
104
1.15
0.12
2.2
1.5
14.8
14.9
pmol/l
0.01
12
87
20
181
1.11
0.12
1.2
1.3
32.8
32.9
nmol/l
0.01
14
156
46
434
1.06
0.12
1.2
1.1
—
—
—
0
0
84
808
1.04
0.11
1.4
1.5
—
—
—
0
0
24
221
1.09
0.11
1.2
1.2
0.0
0.5
u/ml
—
10
86
24
221
1.09
0.11
3.9
2.7
998.3
753.7
e6/l
—
7
85
28
260
1.08
0.10
1.2
1.7
—
—
—
0
0
12
106
1.13
0.09
1.2
1.0
—
—
—
0
0
45
473
0.95
0.09
1.1
1.1
—
—
—
0
0
52
544
0.96
0.09
1.4
1.3
—
—
—
0
0
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
41
389
1.05
0.09
1.4
1.3
—
—
—
0
0
53
507
1.05
0.09
1.3
1.1
—
13.2
—
0
37
11
124
0.89
0.09
1.5
1.9
—
—
—
0
0
11
124
0.89
0.09
1.5
1.9
—
—
—
0
0
11
124
0.89
0.09
1.5
1.9
—
—
—
0
0
11
124
0.89
0.09
1.5
1.9
—
—
—
0
0
47
449
1.05
0.08
1.4
1.6
—
—
—
0
0
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
218
2142
1.02
0.08
1.2
1.2
122.3
156.5
iu/ml
0.71
84
819
38
361
1.05
0.08
1.4
1.9
—
950.0
—
0
16
30
283
1.06
0.08
1.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
67
1.04
0.08
1.0
1.2
—
70.9
—
0
17
7
68
1.03
0.07
1.0
1.2
—
78.5
—
0
18
7
84
0.83
0.07
1.0
1.6
—
—
—
0
0
9
86
1.05
0.07
1.2
1.5
12.0
8.3
ug/l
—
9
86
218
2211
0.98
0.06
2.9
4.1
8.8
20.0
ug/l
1.33
156
1755
67
690
0.97
0.06
1.4
1.4
265.1
300.7
ug/g
0.60
37
377
21
197
1.07
0.06
1.2
1.2
—
—
—
0
0
28
266
1.05
0.06
1.5
1.8
—
—
—
0
0
57
588
0.97
0.06
1.9
3.5
39.7
46.0
mg/l
0.18
44
478
21
223
0.94
0.06
2.3
2.6
—
—
—
0
0
30
286
1.05
0.06
1.1
1.4
759.3
352.2
pmol/l
0.63
19
226
14
129
1.09
0.05
1.1
1.1
139.1
193.5
iu/ml
0.79
14
129
57
587
0.97
0.05
1.9
3.5
39.2
65.9
mg/l
1.19
43
476
42
406
1.03
0.05
1.3
1.3
7.4
7.2
mmol/l
0.16
31
294
18
191
0.94
0.04
2.1
2.5
690.9
626.8
ml
0.23
11
132
21
199
1.06
0.04
1.0
1.1
18.5
10.9
iu/ml
—
7
52
2672
26691
1.01
0.04
4.8
4.4
2.8
2.9
mmol/l
1.76
2514
25016
20
210
0.95
0.03
2.9
3.5
16.1
25.0
mu/l
1.66
20
203
17
179
0.95
0.03
1.1
1.3
—
—
—
0
0
44
451
0.98
0.03
1.1
1.1
—
—
—
0
0
52
510
1.02
0.02
3.0
3.6
58.1
57.3
%
0.19
52
510
15
158
0.95
0.02
1.5
1.5
16.7
24.6
umol/l
0.76
15
150
55
541
1.02
0.02
1.3
1.5
0.6
0.4
nmol/l
0.33
38
425
10
107
0.93
0.02
1.1
1.0
—
—
—
0
0
19
197
0.96
0.01
1.4
1.7
—
—
—
0
0
40
393
1.02
0.01
1.4
1.2
—
—
—
0
0
71
703
1.01
0.01
1.7
1.7
—
—
—
0
0
22
226
0.97
0.00
1.5
1.5
—
—
—
0
0
25
256
0.98
0.00
1.4
1.6
7.1
7.7
mmol/l
0.63
14
161
25
256
0.98
0.00
1.2
1.2
72.4
66.9
u/l
0.18
17
178
43
424
1.01
0.00
1.3
1.4
2.3
4.2
ug/l
1.76
34
380
12
119
1.01
0.00
2.0
1.7
—
—
—
0
0
12
119
1.01
0.00
2.0
1.7
—
—
—
0
0
88
879
1.00
0.00
1.6
1.6
0.1
7.8
iu/ml
0.53
20
163
26
256
1.02
0.00
1.0
1.1
—
—
—
0
0
54
536
1.01
0.00
2.2
2.6
80.1
98.7
ug/min
0.23
33
330
19
187
1.02
0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
5.8
—
0.2
—
0
5
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.3
—
7.4
—
0
6
5
54
0.93
0.00
1.4
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
1148.1
—
0
8
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
7
79
0.89
0.00
2.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_DIVERGSTRAB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_DIVERGSTRAB | 1.402 [1.2, 1.63] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.189 |
During the follow-up period (1.1.1998 — 31.12.2019), 367 out of 5205 females with H7_DIVERGSTRAB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_DIVERGSTRAB | 1.47 [1.26, 1.71] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.019 |
During the follow-up period (1.1.1998 — 31.12.2019), 424 out of 4879 males with H7_DIVERGSTRAB died.
Mortality risk
Mortality risk for people of age
years, who have H7_DIVERGSTRAB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.126% | 0.247% |
| 5 | 0.883% | 1.752% |
| 10 | 1.992% | 4.215% |
| 15 | 3.76% | 8.247% |
| 20 | 6.617% | 14.032% |
Relationships between endpoints
↥Index endpoint: H7_DIVERGSTRAB – Divergent concomitant strabismus
GWS hits: 5
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data